MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0038923
Med Xpress Pharma India LLP
Med Xpress Pharma India LLP - e-commerce in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹12.47 Cr
▲ 2% YoY
Net profit · FY 2023
₹67.96 Lakh
Net margin 5.4%
EBITDA · FY 2023
₹1.01 Cr
EBITDA margin 8.1%
Contribution obligation
₹1.2 Lakh
As per LLP agreement
Open charges
₹6.53 Cr
Secured borrowings
LLP age
10 yrs
Est. 2016
Designated partners
3
As per MCA filings
Active GSTINs
1
GST registered
About Med Xpress Pharma India LLP
Data last updated:
Med Xpress Pharma India LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 08 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAF-8773. Its GSTIN is 27ABCFM5524G1ZD (Maharashtra).
The LLP has a total obligation of contribution of ₹1.2 Lakh. It is led by designated partners including Prafull Babu Kalyanshetti and Mohammadhussain Abdulgani Rayma.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹12.47 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹67.96 Lakh (net margin 5.4%) and EBITDA of ₹1.01 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 425% over three years and 216% over five years.
As per MCA filings, the LLP has open charges of ₹6.53 Cr on record. Court records list 2 cases involving the LLP, including 2 filed against it.
Med Xpress Pharma India LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0038923).
Company details
LLPIN AAF-8773
Incorporation Date 08 March 2016
Total Obligation of Contribution ₹1.2 Lakh
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-18-0038923
Key People
Prafull Babu Kalyanshetti Designated Partner Mohammadhussain Abdulgani Rayma Designated Partner Nitin Kakasaheb Suryavanshi Designated Partner Recognitions & Rankings of Med Xpress Pharma India
Contact details
Med Xpress Pharma India LLP's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address30th Floor A Wing Unit No 3005 – 3006 Marathon Futurex, Nm Joshi Marg Mafatlal Mills Compound Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of Med Xpress Pharma India LLP, buy the company report.
Comprehensive company report
Med Xpress Pharma India LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Med Xpress Pharma India LLP
FY 2025 filings availableMed Xpress Pharma India LLP reported revenue of ₹12.47 Cr (up 2% YoY) for FY 2023.
Revenue · FY 2023
₹12.47 Cr ▲ 2%
Net profit · FY 2023
₹67.96 Lakh margin 5.4%
EBITDA · FY 2023
₹1.01 Cr margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 425%
5 years · compounded
▲ 216%
Revenue has grown at a compounded annual rate (CAGR) of 216% over five years, including 2% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹67.96 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 5.4% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Med Xpress Pharma India LLP, buy the company report.
Designated partners of Med Xpress Pharma India LLP
Med Xpress Pharma India has 3 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prafull Babu Kalyanshetti Also directs: Crecent Health Private Limited | Designated Partner | 08 Mar 2016 | 10 Years 7 Months | Current |
| Mohammadhussain Abdulgani Rayma | Designated Partner | 01 Apr 2025 | 1 Years 6 Months | Current |
| Nitin Kakasaheb Suryavanshi | Designated Partner | 01 Apr 2025 | 1 Years 6 Months | Current |
Charges & borrowings
Open charges
₹6.53 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2025 | 101106704 | Saraswat Coop Bank Limited. | ₹30.5 Lakh | Open | |
| 14 Oct 2024 | 100985882 | Axis Bank Limited | ₹4 Cr | Open | |
| 30 Nov 2023 | 100858134 | Saraswat Coop Bank Ltd | ₹22.9 Lakh | Open | |
| 25 Nov 2022 | 100732364 | Saraswat Coop Bank Ltd | ₹2 Cr | Open |
To see the full charge records of Med Xpress Pharma India LLP, buy the company report.
Total charge records: 4 View all charges
Legal cases
Med Xpress Pharma India LLP has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Sahajanand Medical Technologies Limited Through Authorized Representative Miss Shivani Nayak | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Trivitron Healthcare Pvt Ltd | Disposed |
To see the full case history of Med Xpress Pharma India LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Med Xpress Pharma India LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Med Xpress Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABCFM5524G1ZD | Maharashtra | Active | 19 Aug 2017 |
To see the full GST registrations and return filing status of Med Xpress Pharma India LLP, buy the company report.
Recent activity
Med Xpress Pharma India LLP has 10 designated partner changes on record since 2016: 5 appointments and 5 cessations. The latest: Ankush Ramchandra Jadhav ceased to be Designated Partner on 01 Apr 2025.
Ceased
Ankush Ramchandra Jadhav ceased to be Designated Partner.
Appointed
Mohammadhussain Abdulgani Rayma was appointed as Designated Partner.
Appointed
Nitin Kakasaheb Suryavanshi was appointed as Designated Partner.
AGM
Med Xpress Pharma India Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Med Xpress Pharma India Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Mohammadhussain Abdulgani Rayma ceased to be Partner.
Ceased
Nitin Kakasaheb Suryavanshi ceased to be Partner.
Charges
A charge with Saraswat Coop Bank Limited. amounted to Rs. 30.50 Lakh with Charge ID 101106704 was registered on 28 Mar 2025.
Charges
A charge with Axis Bank Limited of Rs. 400.00 Lakh registered on 14 Oct 2024 with Charge ID 100985882 was modified on 30 Nov 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 400.00 Lakh with Charge ID 100985882 was registered on 14 Oct 2024.
Ceased
Faiza Mumtahir Shaikh ceased to be Designated Partner.
Ceased
Rahul Buvasaheb Bade ceased to be Designated Partner.
6 earlier events are in the company report.
Frequently asked questions
Med Xpress Pharma India is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in online healthcare product retail, within the e-commerce industry. It was incorporated on 08 March 2016 (10+ years old) and is registered under LLPIN AAF-8773.
Med Xpress Pharma India has 3 current designated partners:
- Prafull Babu Kalyanshetti - Designated Partner
- Mohammadhussain Abdulgani Rayma - Designated Partner
- Nitin Kakasaheb Suryavanshi - Designated Partner
The latest financial statements of Med Xpress Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Med Xpress Pharma India is 27ABCFM5524G1ZD, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Med Xpress Pharma India is AAF-8773. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Med Xpress Pharma India has 2 court cases on record: 2 filed against it.
Med Xpress Pharma India was incorporated on 08 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Ankush Ramchandra Jadhav ceased to be Designated Partner on 01 Apr 2025. Mohammadhussain Abdulgani Rayma was appointed as Designated Partner on 01 Apr 2025. Nitin Kakasaheb Suryavanshi was appointed as Designated Partner on 01 Apr 2025. Med Xpress Pharma India has 10 designated partner changes on record in total.
Yes, Med Xpress Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0038923).
The registered office of Med Xpress Pharma India is at 30th Floor A Wing Unit No 3005 – 3006 Marathon Futurex, Nm Joshi Marg Mafatlal Mills Compound Lower Parel, Mumbai, Maharashtra, India – 400013.